Oppenheimer Asset Management Inc. Lowers Stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Oppenheimer Asset Management Inc. lowered its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 8.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 5,967 shares of the biopharmaceutical company’s stock after selling 524 shares during the period. Oppenheimer Asset Management Inc.’s holdings […]
Oppenheimer Asset Management Inc. lowered its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 8.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 5,967 shares of the biopharmaceutical company’s stock after selling 524 shares during the period. Oppenheimer Asset Management Inc.’s holdings […]
